相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。American Cancer Society's report on the status of cancer disparities in the United States, 2021
Farhad Islami et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Cancer statistics for African American/Black People 2022
Angela N. Giaquinto et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108)
Seema A. Khan et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Emerging strategies for TNBC with early clinical data: new chemoimmunotherapy strategies
Peter E. Hall et al.
BREAST CANCER RESEARCH AND TREATMENT (2022)
Racial disparity in distant recurrence-free survival in patients with localized breast cancer: A pooled analysis of National Surgical Adjuvant Breast and Bowel Project trials
Gina Kim et al.
CANCER (2022)
Decreasing Incidence of Estrogen Receptor-Negative Breast Cancer in the United States: Trends by Race and Region
Brittny C. Davis Lynn et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2022)
Systemic Therapy for Advanced Human 3 Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Guideline Update
Sharon H. Giordano et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer
J. Cortes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Association of Medicaid Expansion With Mortality Disparity by Race and Ethnicity Among Patients With De Novo Stage IV Breast Cancer
Catalina Malinowski et al.
JAMA ONCOLOGY (2022)
Cancer treatment and survivorship statistics, 2022
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
The Emergence of the Racial Disparity in US Breast-Cancer Mortality
Ismail Jatoi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
Shanu Modi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Regional Nodal Management in the Setting of Up-Front Surgery
Lior Z. Braunstein et al.
SEMINARS IN RADIATION ONCOLOGY (2022)
Estimation of the Number of Individuals Living With Metastatic Cancer in the United States
Lisa Gallicchio et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2022)
Neighborhood-Level Redlining and Lending Bias Are Associated with Breast Cancer Mortality in a Large and Diverse Metropolitan Area
Lindsay J. Collin et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)
Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial
Kathy S. Albain et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication
D. Miles et al.
ANNALS OF ONCOLOGY (2021)
Neighborhood Social Environmental Factors and Breast Cancer Subtypes among Black Women
Bo Qin et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)
Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium
Anna Morra et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
Larissa A. Korde et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Breast cancer patients' insurance status and residence zip code correlate with early discontinuation of endocrine therapy: An analysis of the ECOG-ACRIN TAILORx trial
Gelareh Sadigh et al.
CANCER (2021)
Cancer Mortality Disparities among Asian American and Native Hawaiian/Pacific Islander Populations in California
Heidy N. Medina et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)
Emerging drugs for the treatment of triple-negative breast cancer: a focus on phase II immunotherapy trials
Peter E. Hall et al.
EXPERT OPINION ON EMERGING DRUGS (2021)
Evaluation of Racial/Ethnic Differences in Treatment and Mortality Among Women With Triple-Negative Breast Cancer
Beomyoung Cho et al.
JAMA ONCOLOGY (2021)
Cancer statistics for the US Hispanic/Latino population, 2021
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Trends in Contralateral Prophylactic Mastectomy Utilization for Small Unilateral Breast Cancer
Alison S. Baskin et al.
JOURNAL OF SURGICAL RESEARCH (2021)
Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics
Farhad Islami et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
Neighborhood disadvantage and individual-level life stressors in relation to breast cancer incidence in US Black women
Lauren E. Barber et al.
BREAST CANCER RESEARCH (2021)
Breast cancer patients' insurance status and residence zip code correlate with early discontinuation of endocrine therapy: An analysis of the ECOG-ACRIN TAILORx trial
Gelareh Sadigh et al.
CANCER (2021)
The Immigrant Health Advantage: An Examination of African-Origin Black Immigrants in the United States
Justin Vinneau Palarino
POPULATION RESEARCH AND POLICY REVIEW (2021)
Male breast cancer in the United States: Treatment patterns and prognostic factors in the 21st century
Siddhartha Yadav et al.
CANCER (2020)
Associations between breast cancer subtype and neighborhood socioeconomic and racial composition among Black and White women
Erin Linnenbringer et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Role of Preoperative MRI in the Management of Newly Diagnosed Breast Cancer Patients
Lisa A. Newman
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2020)
Pembrolizumab for Early Triple-Negative Breast Cancer
Peter Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Deimplementation of the Choosing Wisely Recommendations for Low-Value Breast Cancer Surgery A Systematic Review
Ton Wang et al.
JAMA SURGERY (2020)
Breast cancer treatment delays by socioeconomic and health care access latent classes in black and white women
Marc A. Emerson et al.
CANCER (2020)
Systemic Therapy for Estrogen Receptor-Positive, HER2-Negative Breast Cancer
Harold J. Burstein
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Incident Cases Captured in the National Cancer Database Compared with Those in US Population Based Central Cancer Registries in 2012-2014
Katherine Mallin et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
The high and heterogeneous burden of breast cancer in Hawaii: A unique multiethnic US Population
Lenora W. M. Loo et al.
CANCER EPIDEMIOLOGY (2019)
Breast Cancer Treatment A Review
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Racial Differences in Time to Breast Cancer Surgery and Overall Survival in the US Military Health System
Yvonne L. Eaglehouse et al.
JAMA SURGERY (2019)
Update on triple-negative breast cancer disparities for the United States: A population-based study from the United States Cancer Statistics database, 2010 through 2014
Lia C. Scott et al.
CANCER (2019)
Breast cancer subtypes among Eastern-African-born black women and other black women in the United States
Hyuna Sung et al.
CANCER (2019)
Differences in breast cancer outcomes amongst Black US-born and Caribbean-born immigrants
Priscila Barreto-Coelho et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Trends in stage at diagnosis for young breast cancer patients in the United States
Carol E. DeSantis et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Multilevel Examination of Health Disparity: The Role of Policy Implementation in Neighborhood Context, in Patient Resources, and in Healthcare Facilities on Later Stage of Breast Cancer Diagnosis
Richard B. Warnecke et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)
National trends in contralateral prophylactic mastectomy in women with locally advanced breast cancer
Hinaben Panchal et al.
JOURNAL OF SURGICAL ONCOLOGY (2019)
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
G. von Minckwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Neoadjuvant Chemotherapy Use in Breast Cancer is Greatest in Excellent Responders: Triple-Negative and HER2+Subtypes
Brittany L. Murphy et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012
Sylvia K. Plevritis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Factors That Contributed to Black-White Disparities in Survival Among Nonelderly Women With Breast Cancer Between 2004 and 2013
Ahmedin Jemal et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
J. A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Recent Advances in the Treatment of Breast Cancer
Christy W. S. Tong et al.
FRONTIERS IN ONCOLOGY (2018)
Proportion of US Trends in Breast Cancer Incidence Attributable to Long-term Changes in Risk Factor Distributions
Ruth M. Pfeiffer et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2018)
Pooled Analysis of Nine Cohorts Reveals Breast Cancer Risk Factors by Tumor Molecular Subtype
Mia M. Gaudet et al.
CANCER RESEARCH (2018)
Proportion and Number of Cancer Cases and Deaths Attributable to Potentially Modifiable Risk Factors in the United States
Farhad Islami et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
The Interaction between Genetic Ancestry and Breast Cancer Risk Factors among Hispanic Women: The Breast Cancer Health Disparities Study
Lisa M. Hines et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
N. Masuda et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Health Disparities and Triple-Negative Breast Cancer in African American Women
Lisa A. Newman et al.
JAMA SURGERY (2017)
State Variation in the Receipt of a Contralateral Prophylactic Mastectomy Among Women Who Received a Diagnosis of Invasive Unilateral Early-Stage Breast Cancer in the United States, 2004-2012
Rebecca Nash et al.
JAMA SURGERY (2017)
Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas
Dezheng Huo et al.
JAMA ONCOLOGY (2017)
Breast cancer in Asian Americans in California, 1988-2013: increasing incidence trends and recent data on breast cancer subtypes
Scarlett Lin Gomez et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more personalized approach to cancer staging
Mahul B. Amin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement
Albert L. Siu et al.
ANNALS OF INTERNAL MEDICINE (2016)
Metrics for monitoring cancer inequities: residential segregation, the Index of Concentration at the Extremes (ICE), and breast cancer estrogen receptor status (USA, 1992-2012)
Nancy Krieger et al.
CANCER CAUSES & CONTROL (2016)
Delayed Initiation of Adjuvant Chemotherapy Among Patients With Breast Cancer
Mariana Chavez-MacGregor et al.
JAMA ONCOLOGY (2016)
Breast Cancer Mortality in African-American and Non-Hispanic White Women by Molecular Subtype and Stage at Diagnosis: A Population-Based Study
Li Tao et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
Differences in Breast Cancer Stage at Diagnosis and Cancer-Specific Survival by Race and Ethnicity in the United States
Javaid Iqbal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Breast Cancer Screening for Women at Average Risk 2015 Guideline Update From the American Cancer Society
Kevin C. Oeffinger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors
Erica T. Warner et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Estrogen Receptor Status and the Future Burden of Invasive and In Situ Breast Cancers in the United States
Philip S. Rosenberg et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State
Betsy A. Kohler et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Racial/Ethnic Disparities in Time to a Breast Cancer Diagnosis The Mediating Effects of Health Care Facility Factors
Yamile Molina et al.
MEDICAL CARE (2015)
Bilateral Mastectomy versus Breast-Conserving Surgery for Early-Stage Breast Cancer: The Role of Breast Reconstruction
Claudia R. Albornoz et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2015)
Nationwide Trends in Mastectomy for Early-Stage Breast Cancer
Kristy L. Kummerow et al.
JAMA SURGERY (2015)
Estrogen Receptor Status and the Future Burden of Invasive and In Situ Breast Cancers in the United States
Philip S. Rosenberg et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State
Betsy A. Kohler et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Effects of Screening and Systemic Adjuvant Therapy on ER-Specific US Breast Cancer Mortality
Diego Munoz et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343
Kevin S. Hughes et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Receipt of locoregional therapy among young women with breast cancer
Rachel A. Freedman et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Cancer treatment and survivorship statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Update on Mammography Trends Comparisons of Rates in 2000, 2005, and 2008
Nancy Breen et al.
CANCER (2011)
The Association of Race/Ethnicity, Insurance Status, and Socioeconomic Factors With Breast Cancer Care
Rachel A. Freedman et al.
CANCER (2011)
Breast Cancer Incidence Rates in U.S. Women Are No Longer Declining
Carol DeSantis et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Incidence of Breast Cancer in the United States: Current and Future Trends
William F. Anderson et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
The impact of changes in hormone therapy on breast cancer incidence in the US population
Nathan J. Coombs et al.
CANCER CAUSES & CONTROL (2010)
Are Mastectomies on the Rise? A 13-Year Trend Analysis of the Selection of Mastectomy Versus Breast Conservation Therapy in 5865 Patients
Kandace P. McGuire et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
The decrease in breast-cancer incidence in 2003 in the United States.
Peter M. Ravdin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Trends and disparities in socioeconomic and behavioural characteristics, life expectancy, and cause-specific mortality of native-born and foreign-born populations in the United States, 1979-2003
Gopal K. Singh et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2006)
Effect of screening and adjuvant therapy on mortality from breast cancer
DA Berry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)